The EU must address its dependency on raw materials from Russia and the US to secure its radiopharmaceutical supply, according to the EMA and HMA. They recommend improving transport efficiency and developing EU-based HALEU enrichment capabilities while mapping supply chains. Transport bottlenecks and regulatory inconsistencies hinder timely delivery of radiopharmaceuticals, which are crucial for medical treatments. Teljes cikk (Euronews.com)